Streetbeat News

Regulatory

LH

Labcorp has expanded its STI test offerings by becoming the exclusive U.S. distributor for NOWDiagnostics' First to Know Syphilis Test, the first FDA-authorized over-the-counter blood test for syphilis.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 12:40 pm

DRTS

Alpha Tau Medical Ltd. has treated its first patient with recurrent lung cancer in a clinical trial at Hadassah Medical Center, Israel, using its innovative Alpha DaRT® therapy. The trial aims to assess the safety, feasibility, and efficacy of the treatment.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 12:36 pm

EDBL

Edible Garden has regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing on the exchange. This development is crucial for maintaining investor confidence and access to capital markets.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 12:36 pm

SIBN

SI-BONE, Inc. has announced the first-in-patient procedures using its FDA-designated breakthrough device, the iFuse TORQ TNT Implant System, for pelvic fracture fixation. This system offers significant advancements over traditional methods and has received 510(k) clearance.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 12:34 pm

YYGH

YY Group Holdings Limited (NASDAQ:YYGH) has regained compliance with NASDAQ's Minimum Bid Price Rule by maintaining a stock price above $1.00 for over 12 consecutive business days. The stock has risen by over 70% from a low of $0.71 to a peak of $1.295, reflecting market confidence in the company's growth and business model.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 12:33 pm

PALI

Palisade Bio has received approval from Health Canada to begin a Phase 1 clinical study for its lead program, PALI-2108, aimed at treating ulcerative colitis. The study will explore single and multiple ascending doses and food effects. The global ulcerative colitis market is projected to reach $10 billion by 2028.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 12:31 pm

SPY

The USA Consumer Price Index (CPI) for September increased by 2.4% year-over-year, slightly above the estimated 2.3% but below the prior 2.5%. This indicates a moderate inflationary trend.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 12:31 pm

SPY

The USA Core CPI for September increased by 0.3% month-over-month, surpassing the estimated 0.2% and matching the prior month's increase. This indicates a higher-than-expected inflation rate.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 12:30 pm

SPY

The Core Consumer Price Index (CPI) for September increased by 3.3% year-over-year, surpassing the expected 3.2% and the prior 3.2%. This indicates a higher-than-anticipated inflation rate.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 12:30 pm

SPY

The USA Consumer Price Index (CPI) for September increased by 0.2% month-over-month, surpassing the estimated 0.1% and matching the prior month's increase. This indicates a slight rise in inflationary pressures.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 12:30 pm